Vanguard Global Advisers »

Prime Medicine shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $154k 44k 3.48

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Prime Medicine

Alphabet
BlackRock
Vanguard Group
ARK Investment Management
T. Rowe Price Investment Management
State Street Corporation
Vanguard Capital Management
Balyasny Asset Management
Casdin Capital
Woodline Partners
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
UBS Group
Geode Capital Management
FMR

View all funds holding Prime Medicine